Algert Global’s Cymabay Therapeutics CBAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-84,883
| Closed | -$2.01M | – | 1319 |
|
|
2023
Q4 | $2.01M | Sell |
84,883
-8,003
| -9% | -$189K | 0.08% | 417 |
|
|
2023
Q3 | $1.39M | Buy |
+92,886
| New | +$1.39M | 0.07% | 486 |
|
|
2023
Q2 | – | Sell |
-15,080
| Closed | -$131K | – | 1315 |
|
|
2023
Q1 | $131K | Sell |
15,080
-38,470
| -72% | -$334K | 0.01% | 1068 |
|
|
2022
Q4 | $336K | Sell |
53,550
-5,190
| -9% | -$32.6K | 0.02% | 912 |
|
|
2022
Q3 | $206K | Sell |
58,740
-38,854
| -40% | -$136K | 0.01% | 1035 |
|
|
2022
Q2 | $288K | Buy |
97,594
+49,600
| +103% | +$146K | 0.02% | 929 |
|
|
2022
Q1 | $149K | Buy |
47,994
+860
| +2% | +$2.67K | 0.01% | 1075 |
|
|
2021
Q4 | $159K | Buy |
47,134
+25,450
| +117% | +$85.9K | 0.02% | 883 |
|
|
2021
Q3 | $79K | Buy |
+21,684
| New | +$79K | 0.01% | 981 |
|
|
2021
Q2 | – | Sell |
-31,470
| Closed | -$143K | – | 554 |
|
|
2021
Q1 | $143K | Buy |
31,470
+19,380
| +160% | +$88.1K | 0.05% | 392 |
|
|
2020
Q4 | $69K | Sell |
12,090
-21,740
| -64% | -$124K | 0.02% | 389 |
|
|
2020
Q3 | $245K | Sell |
33,830
-45,520
| -57% | -$330K | 0.08% | 290 |
|
|
2020
Q2 | $277K | Buy |
+79,350
| New | +$277K | 0.09% | 285 |
|